Bespak
Inhaled drug delivery devices
- B2B
- Has physical offices
- Manufacturing
- Hardware
- Sales-led purchase
About Bespak
A global CDMO specializing in inhaled and nasal drug delivery devices, pharmaceutical products, and drug-device combination products for the pharmaceutical industry
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Holmes Chapel, England, United Kingdom
- Founded
- 1959
- Revenue
- $43.1M – $341MTamtam estimate
- Website
- bespak.com
- linkedin.com/company/bespak
Bespak in the news
- Bespak Europe Number of Employees 2026 | Employee Count & Headcount Data
Bespak Europe Ltd. is projected to grow its workforce to 688 employees by March 2026, marking a 38.2% increase from 2023.
- 100 home-scheme refused because of impact on Jodrell Bank and nearby business
A 101-home development was rejected due to its negative impact on Jodrell Bank and Bespak's expansion plans.
- 13/04/2026 - Council celebrates world first green inhaler manufacturer during 'Made in Cheshire' visit
Bespak is manufacturing the world's first low carbon inhaler in Holmes Chapel, supporting green pharmaceutical innovation and local job growth.
- Bespak visit
Bespak launched the first low-carbon inhaler and is expanding into nasal drug delivery from its Holmes Chapel facility.
- Pharmaceutical firm making inhalers leads new Made in Cheshire East business drive
Bespak has been named the lead company for the Made in Cheshire East campaign to highlight regional innovation in sustainable inhaler manufacturing.
Bespak at a glance
Bespak is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Holmes Chapel, England, United Kingdom.
Bespak was founded in 1959.
Bespak has 251–1,000 employees.
Bespak's revenue is $43.1M – $341M (Tamtam estimate).
Selling to companies like Bespak?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies